Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
1.2.1. Pentavalent Market, by Region, 2020-2030 (USD Billion)
1.2.2. Pentavalent Market, by Type, 2020-2030 (USD Billion)
1.2.3. Pentavalent Market, by Formulation Type, 2020-2030 (USD Billion)
1.2.4. Pentavalent Market, by Application, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Pentavalent Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Pentavalent Market Dynamics
3.1. Pentavalent Market Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Rising prevalence of diphtheria
3.1.1.2. Increasing number of immunization programs
3.1.2. Market Challenges
3.1.2.1. High initial cost of pentavalent development
3.1.2.2. Lack of awareness regarding treatment availability
3.1.3. Market Opportunities
3.1.3.1. Growing R&D spending on pentavalent vaccine development activities
3.1.3.2. Increasing strategic initiatives by the key market players
Chapter 4. Global Pentavalent Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Pentavalent Market, by Type
5.1. Market Snapshot
5.2. Global Pentavalent Market by Type, Performance – Potential Analysis
5.3. Global Pentavalent Market Estimates & Forecasts by Type 2020-2030 (USD Billion)
5.4. Pentavalent Market, Sub Segment Analysis
5.4.1. Sodium Stibogluconate
5.4.2. Meglumine Antimoniate
Chapter 6. Global Pentavalent Market, by Formulation Type
6.1. Market Snapshot
6.2. Global Pentavalent Market by Formulation Type, Performance – Potential Analysis
6.3. Global Pentavalent Market Estimates & Forecasts by Formulation Type 2020-2030 (USD Billion)
6.4. Pentavalent Market, Sub Segment Analysis
6.4.1. Lyophilized
6.4.2. Liquid
Chapter 7. Global Pentavalent Market, by Application
7.1. Market Snapshot
7.2. Global Pentavalent Market by Application, Performance – Potential Analysis
7.3. Global Pentavalent Market Estimates & Forecasts by Application 2020-2030 (USD Billion)
7.4. Pentavalent Market, Sub Segment Analysis
7.4.1. Hospitals Pharmacies
7.4.2. Retail Pharmacies
7.4.3. Online Pharmacies
Chapter 8. Global Pentavalent Market, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Pentavalent Market, Regional Market Snapshot
8.4. North America Pentavalent Market
8.4.1. U.S. Pentavalent Market
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Formulation Type breakdown estimates & forecasts, 2020-2030
8.4.1.3. Application breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Pentavalent Market
8.5. Europe Pentavalent Market Snapshot
8.5.1. U.K. Pentavalent Market
8.5.2. Germany Pentavalent Market
8.5.3. France Pentavalent Market
8.5.4. Spain Pentavalent Market
8.5.5. Italy Pentavalent Market
8.5.6. Rest of Europe Pentavalent Market
8.6. Asia-Pacific Pentavalent Market Snapshot
8.6.1. China Pentavalent Market
8.6.2. India Pentavalent Market
8.6.3. Japan Pentavalent Market
8.6.4. Australia Pentavalent Market
8.6.5. South Korea Pentavalent Market
8.6.6. Rest of Asia Pacific Pentavalent Market
8.7. Latin America Pentavalent Market Snapshot
8.7.1. Brazil Pentavalent Market
8.7.2. Mexico Pentavalent Market
8.8. Middle East & Africa Pentavalent Market
8.8.1. Saudi Arabia Pentavalent Market
8.8.2. South Africa Pentavalent Market
8.8.3. Rest of Middle East & Africa Pentavalent Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Sanofi
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. GlaxoSmithKline PLC.
9.3.3. Bristol-Myers Squibb Company
9.3.4. Maiden Pharmaceuticals Limited
9.3.5. Shandong Xinhua Pharmaceutical Co.,Ltd.
9.3.6. Panacea Biotec Ltd.
9.3.7. Biological E. Ltd.
9.3.8. Novartis AG
9.3.9. Shantha Biotechnics Ltd.
9.3.10. Serum Institute of India Pvt. Ltd.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/